Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 13/20 | 0.37 |
| ▸ | CNR1 | P21554 | 9/20 | 0.37 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | THRA | P10827 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3437342 | 0.93 | CNR2 (0.31) | CNR2CNR1 | |
| SCHEMBL22277554 | 0.93 | CNR2 (0.31) | CNR2CNR1 | |
| SCHEMBL9630246 | 0.92 | RIPK1 (0.35) | CNR2CNR1 | |
| SCHEMBL9630298 | 0.92 | RIPK1 (0.35) | CNR2CNR1 | |
| SCHEMBL9630242 | 0.92 | RIPK1 (0.35) | CNR2CNR1 | |
| SCHEMBL9630303 | 0.92 | RIPK1 (0.35) | CNR2CNR1 | |
| SCHEMBL9631488 | 0.91 | RIPK1 (0.34) | CNR2CNR1 | |
| SCHEMBL9631484 | 0.91 | RIPK1 (0.34) | CNR2CNR1 | |
| SCHEMBL9631308 | 0.91 | RIPK1 (0.36) | CNR2 | |
| SCHEMBL9631301 | 0.91 | RIPK1 (0.36) | CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016143634-A1 | LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION, COMPOSITE MATERIAL CONTAINING LIQUID CRYSTAL, AND LIQUID CRYSTAL DISPLAY ELEMENT USING LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION OR COMPOSITE MATERIAL CONTAINING LIQUID CRYSTAL | JNC株式会社 | 2016-09-15 | — | — | WO | disclosed |